EcoDrugPlus

Retinoic Acid Receptor Gamma

Ensembl ID : ENSSTUG00000048976
Gene Symbol: RARG
3 Cross references
345 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSSTUG00000033686
Gene Symbol: RARG
3 Cross references
325 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSSTUG00000029287
Gene Symbol: RARG
3 Cross references
369 Possible Orthologues:

Rho-Associated Protein Kinase 1-Like

Ensembl ID : ENSSTUG00000013818
Gene Symbol: LOC115157216
3 Cross references
206 Possible Orthologues:

Rho-Associated Protein Kinase 1-Like

Ensembl ID : ENSSTUG00000046106
Gene Symbol: LOC115169563
3 Cross references
207 Possible Orthologues:

Rho-Associated Protein Kinase 2-Like

Ensembl ID : ENSSTUG00000020732
Gene Symbol: LOC115162175
3 Cross references
219 Possible Orthologues:

Rho-Associated Protein Kinase 2-Like

Ensembl ID : ENSSTUG00000029880
Gene Symbol: LOC115172456
3 Cross references
218 Possible Orthologues:

Ribosomal Protein L10

Ensembl ID : ENSSTUG00000006450
Gene Symbol: RPL10
3 Cross references
404 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSSTUG00000022306
Gene Symbol: RPL10A
1 Cross references
351 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSSTUG00000013074
Gene Symbol: RPL12
3 Cross references
478 Possible Orthologues:

Ribosomal Protein L21

Ensembl ID : ENSSTUG00000013811
Gene Symbol: RPL21
3 Cross references
778 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSSTUG00000010992
Gene Symbol: RPL22
3 Cross references
160 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).